@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:show . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T20:14:13.151126"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "\"Dex ) s therapeutic activity in severe cases of COVID-19 patients\"" . rdf:OBJECT-POSITION rdfs:label "32"^^xsd:integer . rdf:PREDICATE rdfs:label "shown" . rdf:PREDICATE-POSITION rdfs:label "[120]" . rdf:SUBJECT rdfs:label "dexamethasone ( Dex )" . rdf:SUBJECT-POSITION rdfs:label "-1"^^xsd:integer . rdfs:ABSTRACT-UID ns3:50 "ggiljvum" . rdfs:SENTENCE rdfs:label "Repurposed anti-viral drugs have played a huge role in combating the virus, and most recently, dexamethasone (Dex) have shown dexamethasone (Dex)'s therapeutic activity in severe cases of COVID-19 patients." . rdfs:TRIPLE-UID ns2:ggiljvum-TRIPLE-ABSTRACT-4 "ggiljvum-TRIPLE-ABSTRACT-4" . rdfs:label "dexamethasone" . rdfs:label "severe" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "fN5G78DAivDE6aNSfFnClRbZaUq6plb0DbLaAeaq5tuehs/94eOiyGAp4BAwZW6Lwtr7Br5HkGv8oTDjCYY0vuGZfP4Ashcmxv88s9aDb1eP4BKIonfOY3cGRjtb05l8DlIGa+k8+RqTyXQMA895SYIQfKXV20+9DW0sJslXLFI="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T20:14:13.151126"^^xsd:dateTime; prov:wasAttributedTo . }